[Clinical experiences with the prolactin-inhibiting serotonin antagonist metergoline].
20 puerperal women who did not wish to breast feed their infants were treated with the serotonin antagonist metergoline. In 19 cases effective suppression of puerperal lactation was achieved by the administration of metergoline without the side effects or signs of intolerance. Of 9 women with hyperprolactinaemic amenorrhoea treated with metergoline the raised prolactin level was lowered, followed by menstruation in 7 patients. Ovulation even occurred in 5 of these women. One patient had to discontinue therapy due to intolerance. in normoprolactinaemic amenorrhoea regular menstruation reappeared in 4 out of 5 women; 2 patients even ovulated.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007774:Lactation / Q000187:drug effects*; D008711:Metergoline / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D014839:Vomiting / Q000139:chemically induced
D004873:Ergolines; D008711:Metergoline; D011388:Prolactin
Klinische Erfahrungen mit dem prolaktininhibierenden Serotoninantagonisten Metergolin.